Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 8Recruiting 4Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Head & Neck 5Genitourinary 5Breast 5Gynecologic 3CNS 3Thoracic 2Sarcoma 1Other solid neoplasm 1Lymphoid 1

Conditions

Lymphoma 1

Interventions

Cyclophosphamide 139Rituximab 114Etoposide 77Vincristine 75Doxorubicin 62Cytarabine 61Dexamethasone 58Prednisone 55fludarabine 52Methotrexate 46N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 42Lenalidomide 36Gemcitabine 35Radiotherapy 29Melphalan 27pegaspargase 22Prednisolone 22Ifosfamide 22fludarabine phosphate 20Busulfan 20Cisplatin 19Bendamustine Hydrochloride 19Asparaginase 18Peripheral Blood Stem Cell Transplantation 17Decitabine 16Carmustine 16ibrutinib 15Mercaptopurine 15Filgrastim 15Oxaliplatin 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Magnetic Resonance Imaging × Lymphoid × Clear all
NCT02733887 2016-04-12

MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma

Guangxi Medical University

Phase NA Unknown
66 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡